Better A1C seen in diabetes patients on bile-acid sequestrants

09/27/2013 | Medscape (free registration)

A review presented at the European Association for the Study of Diabetes meeting revealed type 2 diabetes patients who used bile-acid sequestrants attained greater reductions in A1C than those in the placebo group. Bile-acid sequestrants also helped decrease levels of bad cholesterol and did not result in weight gain among patients, researchers noted.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY